爱尔眼科发澄清公告

Core Viewpoint - Aier Eye Hospital Group clarified its non-affiliation with Xiangyang Hengtai Kang Hospital, which has been implicated in violations related to medical insurance fund misuse, following media reports linking the two entities. The company's stock fell by 3.82% after the announcement, closing at 11.07 yuan per share with a total market value of 103.23 billion yuan [1][2]. Group 1: Company Clarification - Aier Eye Hospital stated that Xiangyang Hengtai Kang is not a subsidiary of Aier Eye but a joint venture established by Aier Medical Investment Group and other investors, managed independently by its hospital management team [2][5]. - The company emphasized its commitment to legal compliance and a zero-tolerance policy towards any illegal activities, asserting that it has no ownership or operational ties with Xiangyang Hengtai Kang [2][5]. Group 2: Regulatory Investigation - Following reports of misconduct in several mental health hospitals in Hubei, including Xiangyang Hengtai Kang, a joint investigation team has been formed by local authorities to address allegations of patient mismanagement and insurance fraud [8][10]. - The National Health Commission has dispatched officials to oversee the investigation and ensure compliance with regulations, highlighting the importance of safeguarding patient rights and health [10]. Group 3: Historical Violations - Aier Eye Hospital has a history of administrative penalties related to the misuse of medical insurance funds, with 56 affiliated hospitals reported to have faced fines for similar violations [11][12]. - Recent fines include amounts such as 3,838.12 yuan for improper billing practices and 12,762.64 yuan for repeated charges that resulted in losses to the medical insurance fund [12][14].